• 1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P.R.China;
  • 2. Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R.China;
  • 3. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, P.R.China;
  • 4. Chinese Equator Center, Hong Kong 999077, P.R.China;
  • 5. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, P.R.China;
BIAN Zhaoxiang, Email: bianzxiang@gmail.com
Export PDF Favorites Scan Get Citation

高質量的隨機對照試驗(randomized controlled trials,RCTs)是循證醫學的組成部分。隨機對照試驗是高質量系統評價的基礎,是衛生保健政策和臨床實踐的重要決定因素。為最有效地使用已發表的研究,研究者和作者應遵循準確和透明的 RCTs 報告規范。CONSORT 聲明及其擴展版是生物醫學研究中使用最廣泛的報告規范之一。CONTORT 聲明于 2004 年被 American Journal of Orthodontics and Dentofacial Orthopedics 采用。自 2011 年以來,該期刊一直積極遵守 CONSORT 報告規范。本文旨在解釋 CONSORT 各條目與這一領域研究報告的相關性及其應用,以幫助作者向本雜志和其他矯正類雜志提交 RCTs 報告時,達到 CONSORT 聲明的要求。

Citation: Translated by ZHAO Chen, FU Shufei, DUAN Yuting, ZHANG Chi, SHANG Hongcai, BIAN Zhaoxiang. The CONSORT statement: application within and adaptations for orthodontic trials. Chinese Journal of Evidence-Based Medicine, 2021, 21(2): 219-230. doi: 10.7507/1672-2531.202008177 Copy

Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Implementing Bayesian meta-analysis of binary data using PROC MCMC process step in the SAS software
  • Next Article

    Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement